Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Dr Mathew Martin

Newcastle AuthorsTitleYearFull text
Dr Mathew Martin
Recent advances in kinase drug discovery part i: The editors’ take2021
Gemma Davison
Dr Mathew Martin
Professor Martin Noble
Professor Mike Waring
Crystallographic and electrophilic fragment screening of the SARS-CoV-2 main protease2020
Daniel Wood
Svitlana Korolchuk
Dr Natalie Tatum
Lan Wang
Professor Jane Endicott
et al.		Differences in the conformational energy landscape of CDK1 and CDK2 suggest a mechanism for achieving selective CDK inhibition2019
Daniel Wood
Daniel Lopez Fernandez
Leanne Knight
Islam Al-Khawaldeh
Dr Conghao Gai
et al.		FragLites - minimal, halogenated fragments displaying pharmacophore doublets. An efficient approach to druggability assessment and hit generation2019
Stephanie Myers
Duncan Miller
Dr Lauren Molyneux
Dr Mercedeh Arasta
Dr Ruth Bawn
et al.		Identification of a novel orally bioavailable ERK5 inhibitor with selectivity over p38α and BRD42019
Duncan Miller
Dr Mathew Martin
Santosh Adhikari
Alfie Brennan
Professor Jane Endicott
et al.		Identification of a novel ligand for the ATAD2 bromodomain with selectivity over BRD4 through a fragment growing approach2018
Dr Mathew Martin
Professor Martin Noble
Molecular profiling and combinatorial activity of CCT068127: a potent CDK2 and CDK9 inhibitor2018
Dr Mathew Martin
Dr Helen Lawrence
Aurora Kinase Inhibitors and methods of making and using thereof2017
Christopher Coxon
Dr Suzannah Harnor
Dr Mathew Martin
Dr Benoit Carbain
Professor Bernard Golding
et al.		Cyclin-Dependent Kinase (CDK) Inhibitors; Structure-Activity Relationships and Insights into the CDK-2 Selectivity of 6-Substituted 2-Arylaminopurines2017
Dr Mathew Martin
Structural basis of Wee kinases functionality and inactivation by diverse small molecule inhibitors2017
12